Literature DB >> 21286801

Estrogens in the breast tissue: a systematic review.

Lusine Yaghjyan1, Graham A Colditz.   

Abstract

The role of estrogens in breast carcinogenesis has been investigated at the level of whole body (plasma) and cell (molecular, receptors, etc.). Growing attention focused on the breast tissue being an intracrine organ, with potentially important local estrogen production in the breast. However, very little is known about the local breast tissue estrogen levels. Understanding the role of the tissue estrogens in breast carcinogenesis might open new avenues in breast cancer prevention. This systematic review summarizes published studies that measured local estrogen levels in the breast and offers suggestions for strategies to fill gaps in our existing scientific knowledge.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21286801      PMCID: PMC3652894          DOI: 10.1007/s10552-011-9729-4

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  84 in total

Review 1.  Estrogen and the risk of breast cancer.

Authors:  M Clemons; P Goss
Journal:  N Engl J Med       Date:  2001-01-25       Impact factor: 91.245

Review 2.  Production and actions of estrogens.

Authors:  Christian J Gruber; Walter Tschugguel; Christian Schneeberger; Johannes C Huber
Journal:  N Engl J Med       Date:  2002-01-31       Impact factor: 91.245

3.  Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women.

Authors:  E Riza; I dos Santos Silva; B De Stavola; H L Bradlow; D W Sepkovic; D Linos; A Linos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-06       Impact factor: 4.254

4.  The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.

Authors:  Gail A Greendale; Shana L Palla; Giske Ursin; Gail A Laughlin; Carolyn Crandall; Malcolm C Pike; Beth A Reboussin
Journal:  Am J Epidemiol       Date:  2005-09-21       Impact factor: 4.897

5.  Endogenous sex hormone levels and mammographic density among postmenopausal women.

Authors:  Rulla M Tamimi; Susan E Hankinson; Graham A Colditz; Celia Byrne
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-11       Impact factor: 4.254

Review 6.  Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development.

Authors:  J G Liehr
Journal:  Hum Reprod Update       Date:  2001 May-Jun       Impact factor: 15.610

Review 7.  Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone.

Authors:  Fernand Labrie; Van Luu-The; Claude Labrie; Alain Bélanger; Jacques Simard; Sheng-Xiang Lin; Georges Pelletier
Journal:  Endocr Rev       Date:  2003-04       Impact factor: 19.871

8.  Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry.

Authors:  Xia Xu; Timothy D Veenstra; Stephen D Fox; John M Roman; Haleem J Issaq; Roni Falk; Joseph E Saavedra; Larry K Keefer; Regina G Ziegler
Journal:  Anal Chem       Date:  2005-10-15       Impact factor: 6.986

9.  Sex steroid hormones in serum and tissue of benign and malignant breast tumor patients.

Authors:  E A Mady; E E Ramadan; A A Ossman
Journal:  Dis Markers       Date:  2000       Impact factor: 3.434

Review 10.  Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast.

Authors:  Malathy P V Shekhar; Robert Pauley; Gloria Heppner
Journal:  Breast Cancer Res       Date:  2003-02-20       Impact factor: 6.466

View more
  24 in total

1.  Intratumoral estrogen sulfotransferase induction contributes to the anti-breast cancer effects of the dithiocarbamate derivative TM208.

Authors:  Xi-wei Ji; Guang-ping Chen; Yan Song; Ming Hua; Li-jie Wang; Liang Li; Yin Yuan; Si-yuan Wang; Tian-yan Zhou; Wei Lu
Journal:  Acta Pharmacol Sin       Date:  2015-05-04       Impact factor: 6.150

2.  Cooperative activation of gene expression by agonists and antagonists mediated by estrogen receptor heteroligand dimer complexes.

Authors:  Shuang Liu; Sang Jun Han; Carolyn L Smith
Journal:  Mol Pharmacol       Date:  2013-03-05       Impact factor: 4.436

3.  Estradiol-modified prolactin secretion independently of action potentials and Ca2+ and blockade of outward potassium currents in GH3 cells.

Authors:  Manuel Sánchez; Lorena Suárez; Begoña Cantabrana; Javier Bordallo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-10-17       Impact factor: 3.000

4.  Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers.

Authors:  Jennifer T Loud; Gretchen L Gierach; Timothy D Veenstra; Roni T Falk; Kathryn Nichols; Allison Guttmann; Xia Xu; Mark H Greene; Mitchell H Gail
Journal:  Breast Cancer Res Treat       Date:  2014-01-18       Impact factor: 4.872

Review 5.  Modeling chemical effects on breast cancer: the importance of the microenvironment in vitro.

Authors:  Molly M Morgan; Linda A Schuler; Jordan C Ciciliano; Brian P Johnson; Elaine T Alarid; David J Beebe
Journal:  Integr Biol (Camb)       Date:  2020-03-06       Impact factor: 2.192

Review 6.  Obesity-related protein biomarkers for predicting breast cancer risk: an overview of systematic reviews.

Authors:  Xueyao Wu; Xiaofan Zhang; Yu Hao; Jiayuan Li
Journal:  Breast Cancer       Date:  2020-11-25       Impact factor: 4.239

7.  Hops (Humulus lupulus) inhibits oxidative estrogen metabolism and estrogen-induced malignant transformation in human mammary epithelial cells (MCF-10A).

Authors:  L P Hemachandra; P Madhubhani; R Chandrasena; P Esala; Shao-Nong Chen; Matthew Main; David C Lankin; Robert A Scism; Birgit M Dietz; Guido F Pauli; Gregory R J Thatcher; Judy L Bolton
Journal:  Cancer Prev Res (Phila)       Date:  2011-10-13

8.  Mammary adipose stromal cells derived from obese women reduce sensitivity to the aromatase inhibitor anastrazole in an organotypic breast model.

Authors:  Molly M Morgan; Lisa M Arendt; Elaine T Alarid; David J Beebe; Brian P Johnson
Journal:  FASEB J       Date:  2019-04-19       Impact factor: 5.191

9.  6-Prenylnaringenin from Hops Disrupts ERα-Mediated Downregulation of CYP1A1 to Facilitate Estrogen Detoxification.

Authors:  Ryan T Hitzman; Tareisha L Dunlap; Caitlin E Howell; Shao-Nong Chen; Günter Vollmer; Guido F Pauli; Judy L Bolton; Birgit M Dietz
Journal:  Chem Res Toxicol       Date:  2020-10-12       Impact factor: 3.739

10.  Pubertal Growth, IGF-1, and Windows of Susceptibility: Puberty and Future Breast Cancer Risk.

Authors:  Frank M Biro; Bin Huang; Halley Wasserman; Catherine M Gordon; Susan M Pinney
Journal:  J Adolesc Health       Date:  2020-09-01       Impact factor: 5.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.